Montreal − Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, c…
As the population ages, health care epidemiologist Padma Kaul and cardiologist Paul Armstrong, researchers in the Faculty of Medicine & Dentistry at the University of Alberta, want health-care professionals to talk to their patients about their opti…
(PHILADELPHIA) A molecule known to be involved in progressive heart failure has now been shown to also lead to permanent damage after a heart attack, according to researchers at Thomas Jefferson University.
To prove this novel conclusion, the r…
PORTLAND, Ore. — A study led by researchers in the Oregon Health & Science University Smoking Cessation Center may change the way clinicians make treatment decisions for their patients who smoke.
Their findings published online in the journal …
(Philadelphia) — August 31 — The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation (HHF), …
The disruption of a structural component in heart muscle cells, which is associated with heart failure, appears to occur even before heart function starts to decline, according to a new study by researchers at the University of Iowa Roy J. and L…
Failure to reduce new HIV infections in the United States by 50 percent in the next two years not only will have substantial human consequences, but could cost the nation more than $18 billion. A study by Emory University Rollins School of Public Health professor David Holtgrave, PhD, analyzed the fiscal implications of the failure to meet this national goal set by the Centers for Disease Control and Prevention (CDC) in January 2001. The results will be published in the June issue of the Journal of Acquired Immune Deficiency Syndrome.
Mice lacking only one copy of the gene for CD2-associated protein (CD2AP) appear to be significantly more susceptible to kidney disease and failure than normal mice. Moreover, the mutation appears to impair the elimination of proteins that accumulate in the kidney, a previously unidentified process.
Injecting a person?s own stem cells directly into heart muscle appears safe and useful in treating end-stage heart failure, according to a rapid track report today from Circulation: Journal of the American Heart Association.
Using new DNA microarray technology, researchers have found significant changes in the expression pattern of hundreds of genes in heart muscle cells after mechanical pumps are used to take over from failing hearts. This finding represents a first step, they say, in a line of research that could help predict how heart failure patients will respond when supported by a left ventricular assist device (LVAD). These devices are employed when the heart’s left ventricle — the chamber of the heart that pumps blood throughout the body — is too weak to pump enough blood to nourish the body’s tissues. They have been used as successful short-term “bridges to heart transplant” and are increasingly being considered as long-term heart failure destination therapy, also known as “bridge to recovery.”
A drug that blocks a heart-harming hormone can significantly reduce the risk of death and hospitalization in heart attack patients who have heart failure, with minimal side effects, a new international study released today shows. The life-saving effect began soon after patients begin taking the drug, called eplerenone, following their heart attacks. The effect was especially strong if patients were also on other heart medications, according to the results of the randomized, double-blind, placebo-controlled study of 6,632 patients in 37 countries.
Exercise is good medicine for heart failure patients ? even while they await heart transplantation ? according to a new statement from the American Heart Association published in today’s print issue of Circulation: Journal of the American Heart Association.